RIGL - Rigel Pharmaceuticals
IEX Last Trade
13.45
-0.100 -0.743%
Share volume: 100,019
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$13.55
-0.10
-0.74%
Summary score
35%
Profitability
43%
Dept financing
25%
Liquidity
34%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-1.83%
Return on assets
-7.06%
Return on sales
-52.59%
Return on invested capital
40.52%
Total debt ratio
94.59%
Debt ratio change over timeo
-4.91%
Current Ratio
2.43%
Quick Ratio
2.31%
Cash Position Ratio
1.61%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
16.21%
Return on assets
-3.05%
Return on sales
-13.39%
Return on invested capital
15.75%
Total debt ratio
125.27%
Debt ratio change over timeo
-11.62%
Current Ratio
1.85%
Quick Ratio
1.71%
Cash Position Ratio
1.12%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
26.04%
Return on assets
-5.51%
Return on sales
-23.59%
Return on invested capital
21.06%
Total debt ratio
125.03%
Debt ratio change over time
-60.9%
Current Ratio
1.26%
Quick Ratio
1.17%
Cash Position Ratio
0.68%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-117.09%
Return on assets
-105.58%
Return on sales
-147.13%
Return on invested capital
-74.11%
Total debt ratio
-490.74%
Debt ratio change over time
-4.91%
Current Ratio
-3.81%
Quick Ratio
-3.53%
Cash Position Ratio
-1.46%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RIGL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -1.83% | 13.79% | 34.47% | 7.43% |
| Return on assets | -7.06% | 2.76% | 3.15% | 5.62% |
| Return on sales | -52.59% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 40.52% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 41% | 62% | 68% |
| Total debt ratio | 94.59% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -4.91% | 308.97% | -6.99% | 1.18% |
| Dept financing | 25% | 49% | 24% | 7% |
| Current Ratio | 1.85% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.71% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.12% | 0.36% | 1.28% | 2.93% |
| Liquididy | 49% | 14% | 33% | 75% |
| Short-term ratios | RIGL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 16.21% | 13.77% | 13.25% | 3.8% |
| Return on assets | -3.05% | 2.43% | 1.89% | 3.09% |
| Return on sales | -13.39% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 15.75% | 2.14% | 3.39% | 9.18% |
| Profitability | 50% | 64% | 61% | 70% |
| Total debt ratio | 125.27% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -11.62% | 46.38% | -72.08% | 1.51% |
| Dept financing | 25% | 43% | 19% | 5% |
| Current Ratio | 1.85% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.71% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.12% | 0.36% | 1.28% | 2.93% |
| Liquididy | 27% | 12% | 31% | 75% |